Korean J Ophthalmol.  1989 Jun;3(1):6-10. 10.3341/kjo.1989.3.1.6.

Intraocular infusate with hemocoagulase for the control of bleeding during vitreous surgery

Affiliations
  • 1Department of Ophthalmology, College of Medicine, Kyung-Pook National University, Taegu, Korea.

Abstract

The effects of hemocoagulase in injectable form (hemocoagulating enzymatic fraction of South American snake Bothrops jararaca venom provided by Ravizza) on the control of intraocular bleeding during vitreous surgery were evaluated in rabbit eyes. Intraocular infusion solution with hemocoagulase (1 NIH thrombin unit/100 ml of BSS plus) significantly reduced the bleeding time. Electroretinogram b-wave and electroretinogram c-wave showed no abnormality. Infusate with hemocoagulase (1 NIH thrombin unit/100 ml of BSS plus) is not toxic to retinal tissue and appeared to be a useful agent for the control of intraocular bleeding during vitreous surgery.

Keyword

hemocoagulase; bleeding time; vitrectomy; retinal toxicity

MeSH Terms

Animals
Batroxobin/*administration & dosage
Eye Hemorrhage/*prevention & control
Injections
Rabbits
Serine Endopeptidases/*administration & dosage
*Vitrectomy/adverse effects
Batroxobin
Serine Endopeptidases
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr